文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

接受根治性手术的结直肠癌患者围手术期循环CD56自然杀伤细胞及自然杀伤细胞活性恢复的预后意义

Prognostic significance of perioperative circulating CD56 NK cell and recovery of NK cell activity in patients with colorectal cancer undergoing radical surgery.

作者信息

You Jeng-Fu, Lee Cheng-Chi, Lee Yun-Shien, Chern Yih-Jong, Liao Chun-Kai, Hsu Hung-Chih

机构信息

Department of Colon and Rectal Surgery, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan; College of Medicine, Chang Gung University, Taoyuan, Taiwan.

College of Medicine, Chang Gung University, Taoyuan, Taiwan; Department of Neurosurgery, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan.

出版信息

Transl Oncol. 2025 Feb;52:102198. doi: 10.1016/j.tranon.2024.102198. Epub 2024 Dec 9.


DOI:10.1016/j.tranon.2024.102198
PMID:39657310
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11683267/
Abstract

INTRODUCTION: Natural killer (NK) cell activity (NKA) is downregulated in patients with colorectal cancer (CRC), and its dysfunction is possibly associated with increased risk of recurrence. However, its role in prognosis of CRC remains unclear. Prior research has shown that surgical stress can suppress NKA. This study explores the relationship between NK cell/NKA and clinicopathological factors during the perioperative period in patients with CRC. METHODS: We prospectively enrolled 45 patients with CRC. Venous blood samples were collected preoperatively and on postoperative day 3 (POD3) and 30 (POD30). NKA was assessed by measuring the plasma levels of NK cell-secreted IFN-γ. RESULTS: NKA was significantly reduced on POD3 compared with baseline levels before surgery but showed significant recovery by POD30. NKA on POD30 was considerably higher in patients with advanced disease stages or one or more high-risk preoperative factors. Additionally, a higher NKA recovery in patients with advanced stage exhibited improved recurrence-free survival (RFS) and progression-free survival (PFS) (hazards ratio (HR): 0.2442). Furthermore, an increased percentage of CD56 NK cells and a higher CD56/CD56 NK cell ratio postoperatively on POD30 were associated with better RFS/PFS (HR: 0.2732, P = 0.0433 and HR: 0.2193, P = 0.024, respectively). CONCLUSIONS: Our findings indicate that a notable postoperative increase in CD56 NK cells on POD30, both in percentage and ratio, correlates with a more favorable prognosis in CRC patients. Additionally, higher recovery rates of NKA in patients with advanced stages may offer potential applications in risk stratification and the development of treatment strategies for CRC.

摘要

引言:自然杀伤(NK)细胞活性(NKA)在结直肠癌(CRC)患者中下调,其功能障碍可能与复发风险增加有关。然而,其在CRC预后中的作用仍不清楚。先前的研究表明,手术应激可抑制NKA。本研究探讨CRC患者围手术期NK细胞/NKA与临床病理因素之间的关系。 方法:我们前瞻性纳入了45例CRC患者。在术前、术后第3天(POD3)和第30天(POD30)采集静脉血样本。通过测量NK细胞分泌的干扰素-γ的血浆水平来评估NKA。 结果:与手术前的基线水平相比,POD3时NKA显著降低,但到POD30时显著恢复。疾病分期较晚或有一个或多个术前高危因素的患者在POD30时的NKA明显更高。此外,晚期患者中较高的NKA恢复率表现出无复发生存期(RFS)和无进展生存期(PFS)改善(风险比(HR):0.2442)。此外,术后POD30时CD56 NK细胞百分比增加和CD56/CD56 NK细胞比率升高与更好的RFS/PFS相关(HR分别为:0.2732,P = 0.0433和HR:0.2193,P = 0.024)。 结论:我们的研究结果表明,术后第30天CD56 NK细胞在百分比和比率上的显著增加与CRC患者更有利的预后相关。此外,晚期患者中较高的NKA恢复率可能在CRC的风险分层和治疗策略制定中具有潜在应用价值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e660/11683267/959a73340e4f/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e660/11683267/8a9dcb528f6e/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e660/11683267/ba9785e99a43/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e660/11683267/8a76f03dca3b/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e660/11683267/63b566cbc001/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e660/11683267/959a73340e4f/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e660/11683267/8a9dcb528f6e/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e660/11683267/ba9785e99a43/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e660/11683267/8a76f03dca3b/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e660/11683267/63b566cbc001/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e660/11683267/959a73340e4f/gr5.jpg

相似文献

[1]
Prognostic significance of perioperative circulating CD56 NK cell and recovery of NK cell activity in patients with colorectal cancer undergoing radical surgery.

Transl Oncol. 2025-2

[2]
Gross Total Resection Promotes Subsequent Recovery and Further Enhancement of Impaired Natural Killer Cell Activity in Glioblastoma Patients.

Brain Sci. 2022-8-27

[3]
Lower postoperative natural killer cell activity is associated with positive surgical margins after radical prostatectomy.

J Formos Med Assoc. 2020-11

[4]
Natural Killer Cell IFNγ Secretion is Profoundly Suppressed Following Colorectal Cancer Surgery.

Ann Surg Oncol. 2018-9-5

[5]
Reduction of the CD16(-)CD56bright NK cell subset precedes NK cell dysfunction in prostate cancer.

PLoS One. 2013-11-4

[6]
Characterization of circulating T-, NK-, and NKT cell subsets in patients with colorectal cancer: the peripheral blood immune cell profile.

Cancer Immunol Immunother. 2019-5-3

[7]
A Comparison of Cellular Immune Response and Immunological Biomarkers in Laparoscopic Surgery for Colorectal Cancer and Benign Disorders.

Clin Colorectal Cancer. 2024-12

[8]
Effects of the NK cell recovery on outcomes of unmanipulated haploidentical blood and marrow transplantation for patients with hematologic malignancies.

Biol Blood Marrow Transplant. 2008-3

[9]
KLRF1, a novel marker of CD56 NK cells, predicts improved survival for patients with locally advanced bladder cancer.

Cancer Med. 2023-4

[10]
PRMT5 highly expressed on CD16 + CD56- natural killer cells is correlated with NK cells exhaustion in colorectal cancer mesenchyme.

Cancer Immunol Immunother. 2025-3-8

本文引用的文献

[1]
Prognostic Significance of the Royal Marsden Hospital (RMH) Score in Patients with Cancer: A Systematic Review and Meta-Analysis.

Cancers (Basel). 2024-5-11

[2]
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.

CA Cancer J Clin. 2024

[3]
Immune checkpoint inhibitor-related hearing loss: a systematic review and analysis of individual patient data.

Support Care Cancer. 2023-10-11

[4]
Hypertransaminasemia in cancer patients receiving immunotherapy and immune-based combinations: the MOUSEION-05 study.

Cancer Immunol Immunother. 2023-6

[5]
Contribution of natural killer cells in innate immunity against colorectal cancer.

Front Oncol. 2023-1-4

[6]
Fashionable, but What is Their Real Clinical Usefulness? NLR, LMR, and PLR as a Promising Indicator in Colorectal Cancer Prognosis: A Systematic Review.

J Inflamm Res. 2023-1-7

[7]
Gross Total Resection Promotes Subsequent Recovery and Further Enhancement of Impaired Natural Killer Cell Activity in Glioblastoma Patients.

Brain Sci. 2022-8-27

[8]
The Association between the Pan-Immune-Inflammation Value and Cancer Prognosis: A Systematic Review and Meta-Analysis.

Cancers (Basel). 2022-5-27

[9]
Peripheral neuropathy and headache in cancer patients treated with immunotherapy and immuno-oncology combinations: the MOUSEION-02 study.

Expert Opin Drug Metab Toxicol. 2021-12

[10]
Postoperative Natural Killer Cell Dysfunction: The Prime Suspect in the Case of Metastasis Following Curative Cancer Surgery.

Int J Mol Sci. 2021-10-21

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索